In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Mayo Clinic
Medicenna Therapeutics, Inc.
UNICANCER
Massachusetts General Hospital
Genzada Pharmaceuticals USA, Inc.
Xencor, Inc.
Case Comprehensive Cancer Center